Transgression of Race, Gender, and Class:
Crossings: A Journal of English Studies · 2023
DOI: 10.59817/cjes.v14i.483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Crossings: A Journal of English Studies, 2023. Verfasst von Subrata Chandra Mozumder. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper aims to explore Mary Ann Shadd’s transgression of race, gender, and class boundaries by employing a close reading of the text, A Plea for Emigration. I will explore the triangular relationship between race, class, and gender seen in the text from intersectional feminist perspectives. My contention is that, through her activism by pen, especially in A Plea for Emigration, Shadd exposes the feminist voice that enables her to protest against racism, slavery, gender stratification, and marginalization based on class hierarchy. In other words, I claim that Shadd’s transgression of the borders of race, gender, and class lies in her activism and ideology as a woman, black, and marginalized. This paper will, therefore, show that Mary Ann Shadd strongly transgresses the borders of race, gender, and class as the first black woman who owned and edited a newspaper, inspired American blacks towards freedom, confronted her contemporary male leaders, exposed the female gaze during a period of history when the male gaze was predominant and authoritative, became a public speaker making the world listen to her while working with the so-called socially aesthetic people despite being a “negro”.
Zitieren
APA
Mozumder, S. C. (2023). Transgression of Race, Gender, and Class:. Crossings: A Journal of English Studies. https://doi.org/10.59817/cjes.v14i.483
Vancouver
Mozumder SC. Transgression of Race, Gender, and Class:. Crossings: A Journal of English Studies. 2023. doi:10.59817/cjes.v14i.483
BibTeX
@article{Mozumder2023,
author = {Mozumder, Subrata Chandra},
title = {Transgression of Race, Gender, and Class:},
journal = {Crossings: A Journal of English Studies},
year = {2023},
doi = {10.59817/cjes.v14i.483}
}
EUVIMED